a hrefhttps:www.fiercepharma.compharmavertex-acquires-endocrine-disease-specialist-crinetics-10b hreflangenVertex, in its largest-ever deal, acquires endocrine disease specialist Crinetics for 10B a
Vertex Pharmaceuticals has struck a 10 billion dealits largest evertonbspacquire endocrine disease specialist Crinetics Pharmaceuticals. The transactions two focuses, Palsonify and atumelnant, have combined peak sales potential of more than 5 billion, Vertex said.
Read the full story at Fierce Pharma ↗